| Announce Date | 07/30/2025 | 
| EPS Normalized Actual | $0.2 (Miss by $-0.04) | 
| EPS GAAP Actual | $0.2 (Miss by $-0.04) | 
| Revenue Actual | $0.559B | 
| Revenue Surprise | Beat by $559M | 
| Announce Date | 10/01/2025 (Pre-Market) | 
| EPS Normalized Estimate | $1.03 | 
| EPS GAAP Estimate | $1.03 | 
| Revenue Estimate | $0.6431152B | 
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| Dec 2029 | 4.38 | 7.48 | 4.24091 | 4.4684 | 1 | 
| Dec 2028 | 4.43 | 7.4 | 4.26201 | 4.53284 | 1 | 
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss | 
|---|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | -0.56 | -0.56 | 0.559B | 6.34% | 559M | 
| FQ1 2025 (Mar 2025) | 0.57 | 0.57 | 0.553534B | 0.21% | 553.53M | 
| FQ4 2024 (Dec 2024) | 0.49 | 0.49 | 0.582318B | 10.75% | 582.32M | 
| FQ3 2024 (Sep 2024) | 0.78 | 0.78 | 0.62117B | 11.02% | 621.17M | 
| FQ2 2024 (Jun 2024) | 0.5 | 0.5 | 0.523553B | 14.95% | 523.55M | 
| FQ1 2024 (Mar 2024) | 0.61 | 0.61 | 0.552381B | 16.03% | 552.38M | 
| FQ4 2023 (Dec 2023) | 0.49 | 0.49 | 0.519714B | 9.44% | 519.71M | 
| FQ3 2023 (Sep 2023) | 0.88 | 0.88 | 0.552732B | 100% | 552.73M | 
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
1.03
Consensus Revenue Estimates
0.6431152B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.59285 | -- | 0.57874 | 0.61954 | 2 | 
| FQ3 2027 (Sep 2027) | 1.18 | -- | 1.14496 | 1.20099 | 2 | 
| FQ2 2027 (Jun 2027) | 0.84 | -- | 0.81505 | 0.85494 | 2 | 
| FQ1 2027 (Mar 2027) | 0.64 | -- | 0.62099 | 0.65139 | 2 | 
| FQ4 2026 (Oct 2026) | 1.12 | -- | 1.07535 | 1.14777 | 3 | 
| FQ3 2026 (Jul 2026) | 0.68 | -- | 0.65289 | 0.69686 | 3 | 
| FQ2 2026 (Jun 2026) | 0.71 | 178.87 | 0.67648 | 0.72863 | 4 | 
| FQ1 2026 (Mar 2026) | 0.73 | 21.92 | 0.69554 | 0.74916 | 5 | 
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.79B | -- | 0.78B | 0.82B | 3 | 
| FQ3 2027 (Sep 2027) | 0.84B | -- | 0.82B | 0.85B | 2 | 
| FQ2 2027 (Jun 2027) | 0.73B | -- | 0.71B | 0.74B | 2 | 
| FQ1 2027 (Mar 2027) | 0.74B | -- | 0.72B | 0.75B | 2 | 
| FQ4 2026 (Oct 2026) | 0.66B | -- | 0.64B | 0.67B | 4 | 
| FQ3 2026 (Jul 2026) | 0.56B | -- | 0.55B | 0.58B | 4 | 
| FQ2 2026 (Jun 2026) | 0.55B | -1.48 | 0.53B | 0.56B | 5 | 
| FQ1 2026 (Mar 2026) | 0.58B | 3.93 | 0.56B | 0.59B | 6 | 
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 | 
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 | 
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 | 
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 | 
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 | 
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 | 
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 | 
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 | 
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % | 
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | -0.56 | -0.56 | 100% | |
| FQ1 2025 (Mar 2025) | 0.57 | 0.57 | 100% | |
| FQ4 2024 (Dec 2024) | 0.49 | 0.49 | 100% | |
| FQ3 2024 (Sep 2024) | 0.78 | 0.78 | 100% | |
| FQ2 2024 (Jun 2024) | 0.5 | 0.5 | 100% | |
| FQ1 2024 (Mar 2024) | 0.61 | 0.61 | 100% | |
| FQ4 2023 (Dec 2023) | 0.49 | 0.49 | 100% | |
| FQ3 2023 (Sep 2023) | 0.88 | 0.88 | 100% | 
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % | 
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | $0B | $0.56B | $559M | 100% | 
| FQ1 2025 (Mar 2025) | $0B | $0.55B | $553.53M | 100% | 
| FQ4 2024 (Dec 2024) | $0B | $0.58B | $582.32M | 100% | 
| FQ3 2024 (Sep 2024) | $0B | $0.62B | $621.17M | 100% | 
| FQ2 2024 (Jun 2024) | $0B | $0.52B | $523.55M | 100% | 
| FQ1 2024 (Mar 2024) | $0B | $0.55B | $552.38M | 100% | 
| FQ4 2023 (Dec 2023) | $0B | $0.52B | $519.71M | 100% | 
| FQ3 2023 (Sep 2023) | $0B | $0.55B | $552.73M | 100% |